KinBio is a rapidly growing biopharmaceutical company based in Rehovot, Israel, with its main focus on developing needed therapies as well as offering a wide range of CDMO services – from concept to product. KinBio’s main...
KinBio is a rapidly growing biopharmaceutical company based in Rehovot, Israel, with its main focus on developing needed therapies as well as offering a wide range of CDMO services – from concept to product. KinBio’s main focus is to pursue opportunities in the global pharmaceutical market. Augmented by a global group of affiliated companies, Kinbio specializes in research, development, manufacturing and commercialization of biopharmaceutical products. Kinbio’s commitment to top standard quality is inherent across the entire global organization, from our FDA approved cGMP sites to our state of the art R&D laboratories.
The year 1969, was a momentous beginning for the pharmaceutical industry in India. Around four decades ago, the first Indo-Japanese venture was inked and a new entity known as Uni-Sankyo was born. The company was the first to...
The year 1969, was a momentous beginning for the pharmaceutical industry in India. Around four decades ago, the first Indo-Japanese venture was inked and a new entity known as Uni-Sankyo was born. The company was the first to manufacture fungal diastase and other enzymes, which had a huge demand in India. The professional approach of the Japanese corporation Sankyo, which joined hands with us, also saw the introduction of LAB, a probiotic, in India which is marketed both in the tablet and powder form.